Aminopyrimidines as Syk inhibitors
US8735417B2 · kind B2 · utility
35Cited by
6References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 16, 2010 |
| Grant date | May 27, 2014 |
| Priority date | — |
| Expiry date | May 26, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides novel pyrimidine amines of formula (I) which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD and rheumatoid arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.